abrdn Healthcare Investors
About this Fund
abrdn Healthcare Investors is a leading mutual fund company that specializes in providing expert asset management solutions to investors seeking to capitalize on the growth potential of the healthcare sector. With a strong focus on investment excellence and a commitment to delivering exceptional returns, abrdn Healthcare Investors offers a diverse range of mutual funds that cater to the unique needs and risk profiles of its investors. The company's portfolio of funds includes equity, debt, and hybrid options, allowing investors to choose from a variety of investment strategies that align with their financial goals and objectives. For those seeking a disciplined and consistent approach to investing, abrdn Healthcare Investors also offers systematic investment plans (SIPs) that enable investors to invest a fixed amount of money at regular intervals, thereby reducing the impact of market volatility and timing risks. As a trusted name in the wealth management industry, abrdn Healthcare Investors is dedicated to helping its investors achieve their long-term financial objectives through a combination of rigorous research, careful portfolio construction, and ongoing monitoring and evaluation. The company's investment team comprises experienced professionals with a deep understanding of the healthcare sector, including its trends, challenges, and opportunities. By leveraging their expertise and insights, abrdn Healthcare Investors is able to identify attractive investment opportunities and create portfolios that are well-positioned to deliver strong returns over the long term. Whether investors are seeking to grow their wealth, generate income, or preserve their capital, abrdn Healthcare Investors offers a range of mutual fund options that can help them achieve their goals. With its strong investment capabilities, customer-centric approach, and commitment to transparency and accountability, abrdn Healthcare Investors has established itself as a trusted partner for investors seeking to navigate the complexities of the healthcare sector and achieve their financial aspirations. The company's investor-focused approach is built around a deep understanding of the needs and concerns of its clients, including individual investors, financial advisors, and institutional investors. By providing timely and relevant information, responsive customer service, and ongoing support and guidance, abrdn Healthcare Investors helps its investors make informed decisions and stay on track with their investment plans. As a result, the company has earned a reputation for excellence and trust among its investors, who appreciate its commitment to delivering exceptional investment results and outstanding client service. With its expertise in asset management, investment research, and portfolio management, abrdn Healthcare Investors is well-positioned to help its investors succeed in an increasingly complex and dynamic investment landscape. By choosing abrdn Healthcare Investors, investors can tap into the company's extensive knowledge and experience, gain access to a range of high-quality mutual funds, and benefit from a wealth management approach that is tailored to their unique needs and objectives.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABT Abbott Laboratories Since 2026-05-10 | 002824100 | Equity (Common) |
1.81%
|
$21.12 | 168,607 |
| 2 | ABBV AbbVie Inc Since 2026-05-10 | 00287Y109 | Equity (Common) |
0.75%
|
$8.71 | 38,114 |
| 3 | JBIO Jade Biosciences Inc Since 2026-05-10 | 008064206 | Equity (Common) |
0.78%
|
$9.10 | 589,729 |
| 4 | ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 | 02043Q107 | Equity (Common) |
1.50%
|
$17.50 | 43,997 |
| 5 | AMGN Amgen Inc Since 2026-05-10 | 031162100 | Equity (Common) |
3.41%
|
$39.79 | 121,573 |
| 6 | AQST Aquestive Therapeutics Inc Since 2026-05-10 | 03843E104 | Equity (Common) |
0.31%
|
$3.57 | 553,298 |
| 7 | ACLX Arcellx Inc Since 2026-05-10 | 03940C100 | Equity (Common) |
0.23%
|
$2.66 | 40,802 |
| 8 | RCUS Arcus Biosciences Inc Since 2026-05-10 | 03969F109 | Equity (Common) |
0.28%
|
$3.23 | 135,668 |
| 9 | ARQT Arcutis Biotherapeutics Inc Since 2026-05-10 | 03969K108 | Equity (Common) |
0.75%
|
$8.78 | 302,408 |
| 10 | ARWR Arrowhead Pharmaceuticals Inc Since 2026-05-10 | 04280A100 | Equity (Common) |
0.94%
|
$11.01 | 165,758 |
| 11 | AZN AstraZeneca PLC Since 2026-05-10 | 046353108 | Equity (Common) |
0.75%
|
$8.70 | 94,624 |
| 12 | AXSM Axsome Therapeutics Inc Since 2026-05-10 | 05464T104 | Equity (Common) |
0.91%
|
$10.56 | 57,848 |
| 13 | BCRX BioCryst Pharmaceuticals Inc Since 2026-05-10 | 09058V103 | Equity (Common) |
0.26%
|
$3.06 | 392,172 |
| 14 | CRL Charles River Laboratories International Inc Since 2026-05-10 | 159864107 | Equity (Common) |
0.65%
|
$7.57 | 37,946 |
| 15 | CDXS Codexis Inc Since 2026-05-10 | 192005106 | Equity (Common) |
0.73%
|
$8.53 | 5,232,466 |
| 16 | CRBP Corbus Pharmaceuticals Holdings Inc Since 2026-05-10 | 21833P301 | Equity (Common) |
0.54%
|
$6.33 | 778,031 |
| 17 | CRNX Crinetics Pharmaceuticals Inc Since 2026-05-10 | 22663K107 | Equity (Common) |
1.63%
|
$19.06 | 409,392 |
| 18 | DNLI Denali Therapeutics Inc Since 2026-05-10 | 24823R105 | Equity (Common) |
1.86%
|
$21.65 | 1,311,234 |
| 19 | DXCM Dexcom Inc Since 2026-05-10 | 252131107 | Equity (Common) |
0.63%
|
$7.36 | 110,846 |
| 20 | IRON Disc Medicine Inc Since 2026-05-10 | 254604101 | Equity (Common) |
0.46%
|
$5.37 | 67,652 |
| 21 | DYN Dyne Therapeutics Inc Since 2026-05-10 | 26818M108 | Equity (Common) |
0.75%
|
$8.78 | 448,685 |
| 22 | EWTX Edgewise Therapeutics Inc Since 2026-05-10 | 28036F105 | Equity (Common) |
1.00%
|
$11.65 | 469,325 |
| 23 | EVMN Evommune Inc Since 2026-05-10 | 30054Y107 | Equity (Common) |
0.51%
|
$6.01 | 350,795 |
| 24 | EYPT EyePoint Inc Since 2026-05-10 | 30233G209 | Equity (Common) |
1.67%
|
$19.52 | 1,068,537 |
| 25 | GILD Gilead Sciences Inc Since 2026-05-10 | 375558103 | Equity (Common) |
0.32%
|
$3.69 | 30,027 |
| 26 | GRAL GRAIL Inc Since 2026-05-10 | 384747101 | Equity (Common) |
0.61%
|
$7.13 | 83,325 |
| 27 | GH Guardant Health Inc Since 2026-05-10 | 40131M109 | Equity (Common) |
0.35%
|
$4.08 | 39,905 |
| 28 | HUM Humana Inc Since 2026-05-10 | 444859102 | Equity (Common) |
1.55%
|
$18.09 | 70,622 |
| 29 | IDYA Ideaya Biosciences Inc Since 2026-05-10 | 45166A102 | Equity (Common) |
1.02%
|
$11.94 | 345,344 |
| 30 | IMVT Immunovant Inc Since 2026-05-10 | 45258J102 | Equity (Common) |
1.62%
|
$18.88 | 742,624 |
| 31 | IMUX Immunic Inc Since 2026-05-10 | 4525EP101 | Equity (Common) |
0.22%
|
$2.53 | 4,738,771 |
| 32 | INSP Inspire Medical Systems Inc Since 2026-05-10 | 457730109 | Equity (Common) |
1.49%
|
$17.42 | 188,834 |
| 33 | ISRG Intuitive Surgical Inc Since 2026-05-10 | 46120E602 | Equity (Common) |
1.26%
|
$14.68 | 25,913 |
| 34 | IQV IQVIA Holdings Inc Since 2026-05-10 | 46266C105 | Equity (Common) |
0.38%
|
$4.44 | 19,691 |
| 35 | KRYS Krystal Biotech Inc Since 2026-05-10 | 501147102 | Equity (Common) |
0.53%
|
$6.22 | 25,239 |
| 36 | LENZ LENZ Therapeutics Inc Since 2026-05-10 | 52635N103 | Equity (Common) |
0.46%
|
$5.34 | 333,822 |
| 37 | MRK Merck & Co Inc Since 2026-05-10 | 58933Y105 | Equity (Common) |
1.45%
|
$16.92 | 160,742 |
| 38 | MOH Molina Healthcare Inc Since 2026-05-10 | 60855R100 | Equity (Common) |
1.00%
|
$11.69 | 67,362 |
| 39 | NEO NeoGenomics Inc Since 2026-05-10 | 64049M209 | Equity (Common) |
0.79%
|
$9.19 | 781,788 |
| 40 | NBIX Neurocrine Biosciences Inc Since 2026-05-10 | 64125C109 | Equity (Common) |
0.23%
|
$2.71 | 19,103 |
| 41 | NUVL Nuvalent Inc Since 2026-05-10 | 670703107 | Equity (Common) |
0.83%
|
$9.64 | 95,867 |
| 42 | PSNL Personalis Inc Since 2026-05-10 | 71535D106 | Equity (Common) |
1.29%
|
$15.09 | 1,895,842 |
| 43 | PRAX Praxis Precision Medicines Inc Since 2026-05-10 | 74006W207 | Equity (Common) |
1.29%
|
$15.09 | 51,206 |
| 44 | REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 | 75886F107 | Equity (Common) |
2.81%
|
$32.79 | 42,487 |
| 45 | RVMD Revolution Medicines Inc Since 2026-05-10 | 76155X100 | Equity (Common) |
0.52%
|
$6.10 | 76,590 |
| 46 | SRPT Sarepta Therapeutics Inc Since 2026-05-10 | 803607100 | Equity (Common) |
1.74%
|
$20.26 | 941,560 |
| 47 | SERA Sera Prognostics Inc Since 2026-05-10 | 81749D107 | Equity (Common) |
0.29%
|
$3.38 | 1,145,722 |
| 48 | SPRY ARS Pharmaceuticals Inc Since 2026-05-10 | 82835W108 | Equity (Common) |
1.41%
|
$16.49 | 1,415,750 |
| 49 | SION Sionna Therapeutics Inc Since 2026-05-10 | 829401108 | Equity (Common) |
2.06%
|
$24.09 | 585,546 |
| 50 | SLNO Soleno Therapeutics Inc Since 2026-05-10 | 834203309 | Equity (Common) |
0.75%
|
$8.80 | 190,001 |
| 51 | SMMT Summit Therapeutics Inc Since 2026-05-10 | 86627T108 | Equity (Common) |
0.90%
|
$10.54 | 602,438 |
| 52 | TNDM Tandem Diabetes Care Inc Since 2026-05-10 | 875372203 | Equity (Common) |
0.54%
|
$6.34 | 288,261 |
| 53 | TECX Tectonic Therapeutic Inc Since 2026-05-10 | 878972108 | Equity (Common) |
1.38%
|
$16.08 | 770,940 |
| 54 | TEM Tempus AI Inc Since 2026-05-10 | 88023B103 | Equity (Common) |
0.85%
|
$9.95 | 168,493 |
| 55 | TMO Thermo Fisher Scientific Inc Since 2026-05-10 | 883556102 | Equity (Common) |
0.72%
|
$8.39 | 14,478 |
| 56 | TVTX Travere Therapeutics Inc Since 2026-05-10 | 89422G107 | Equity (Common) |
1.02%
|
$11.94 | 312,492 |
| 57 | TCRX TScan Therapeutics Inc Since 2026-05-10 | 89854M101 | Equity (Common) |
0.07%
|
$0.84 | 843,548 |
| 58 | RARE Ultragenyx Pharmaceutical Inc Since 2026-05-10 | 90400D108 | Equity (Common) |
1.84%
|
$21.50 | 934,901 |
| 59 | PCVX Vaxcyte Inc Since 2026-05-10 | 92243G108 | Equity (Common) |
2.51%
|
$29.29 | 634,734 |
| 60 | VIR Vir Biotechnology Inc Since 2026-05-10 | 92764N102 | Equity (Common) |
0.45%
|
$5.30 | 879,214 |
| 61 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative | — | — | 5,247,245 |
| 62 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative |
0.24%
|
$2.80 | 5,247,245 |
| 63 | IMUX IMMUNIC INC. Since 2026-05-10 | — | Derivative |
0.09%
|
$1.03 | 5,247,245 |
| 64 | XENE Xenon Pharmaceuticals Inc Since 2026-05-10 | 98420N105 | Equity (Common) |
1.74%
|
$20.29 | 452,730 |
| 65 | ZTS Zoetis Inc Since 2026-05-10 | 98978V103 | Equity (Common) |
1.09%
|
$12.72 | 101,117 |
| 66 | JAZZ Jazz Pharmaceuticals PLC Since 2026-05-10 | — | Equity (Common) |
0.69%
|
$8.07 | 47,492 |
| 67 | MDT Medtronic PLC Since 2026-05-10 | — | Equity (Common) |
0.88%
|
$10.26 | 106,833 |
| 68 | OCS Oculis Holding AG Since 2026-05-10 | — | Equity (Common) |
0.99%
|
$11.57 | 579,536 |